Safinamide T6651L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Safinamide is a drug indicated for the treatment of Parkinson's disease with multiple methods of action. Potential additional uses might be restless leg syndrome and epilepsy. Safinamide is a reversible and selective monoamine oxidase B inhibitor, reducin
CAS nr:
133865-89-1
Purity:
98%
Molecular Weight:
302,35
SMILES:
C[C@H](NCC1=CC=C(OCC2=CC=CC(F)=C2)C=C1)C(N)=O
Formula:
C17H19FN2O2
Pathway:
Target:
